Fate Therapeutics Inc (NASDAQ:FATE)
| 38.22 Delayed Data As of 4:00pm ET |  -1.05 / -2.67%Today’s Change | 37.97 Today|||52-Week Range 119.85 | -34.68% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Tahl Cindy R Secretary & General Counsel |  Sale | 7/01/2021 | 50,000 | $84.56 | $4.2M | -58.31% |
Wolchko J Scott President & Chief Executive Officer | Sale | 4/22/2021 | 30,000 | $85.54 | $2.6M | -53.33% |
Wolchko J Scott President & Chief Executive Officer | Sale | 7/23/2021 | 30,000 | $85.28 | $2.6M | -54.39% |
Wolchko J Scott President & Chief Executive Officer | Sale | 4/23/2021 | 30,000 | $85.24 | $2.6M | -53.94% |
Wolchko J Scott President & Chief Executive Officer | Sale | 7/22/2021 | 21,773 | $86.19 | $1.9M | -54.27% |
Wolchko J Scott President & Chief Executive Officer | Sale | 10/22/2021 | 30,000 | $58.88 | $1.8M | -33.37% |
Wolchko J Scott President & Chief Executive Officer | Sale | 8/19/2021 | 20,000 | $88.01 | $1.8M | -54.09% |
Tahl Cindy R Secretary & General Counsel | Sale | 1/03/2022 | 27,812 | $59.86 | $1.7M | -34.79% |
Wolchko J Scott President & Chief Executive Officer | Sale | 5/20/2021 | 20,000 | $77.16 | $1.5M | -49.11% |
Valamehr Bahram Chief Development Officer | Sale | 6/14/2021 | 16,380 | $89.11 | $1.5M | -56.31% |
Page of 17